J. Conrad Schwab

Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study

Deverick J. Anderson, Luke F. Chen, David J. Weber et al. · The Lancet · 2017 · 353 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection)

Deverick J. Anderson, Rebekah W. Moehring, David J. Weber et al. · The Lancet Infectious Diseases · 2018 · 128 citations

Pharmacy, Infectious Diseases, Microbiology +16

Implementation Lessons Learned From the Benefits of Enhanced Terminal Room (BETR) Disinfection Study: Process and Perceptions of Enhanced Disinfection with Ultraviolet Disinfection Devices

Deverick J. Anderson, Lauren P. Knelson, Rebekah W. Moehring et al. · Infection Control and Hospital Epidemiology · 2018 · 38 citations · Full text

Health Professions, Health Services Administration, Nursing Administration +13

The Importance of Penetration of Antimicrobial Agents into Cells

J. Conrad Schwab, Gerald L. Mandell · Infectious Disease Clinics of North America · 1989 · 37 citations

Life Sciences, Cell Biology, Microbiology +12